Efficacy and safety of liraglutide versus placebo added to basal insulin analogues (with or without metformin) in patients with type 2 diabetes: a randomized, placebo-controlled trial

Julkaisu

Reference

Ahmann A, Rodbard HW, Rosenstock J, Lahtela JT, de Loredo L, Tornoe K, Boopalan A, Nauck MA. Efficacy and safety of liraglutide versus placebo added to basal insulin analogues (with or without metformin) in patients with type 2 diabetes: a randomized, placebo-controlled trial. Diabetes Obes Metab 2015:17(11):1056-1064.

Julkaisutiedot

Julkaisutyyppi: Alkuperäisartikkeli.
Kansainvälinen.
Kieli: Englanti.

Teksti/tiivistelmä: https://www.ncbi.nlm.nih.gov/pubmed/26179619

Publication data

Publication type: Original scientific article.
International.
In English.

Text/summary: https://www.ncbi.nlm.nih.gov/pubmed/26179619

Tekijät

Contributors

Tampereen yliopisto

Lääketieteen laitos/sisätautioppi
- Jorma Lahtela

University of Tampere

Medical School/Department of Internal Medicine
- Jorma Lahtela

Tampereen yliopistollinen sairaala

Sisätautien vastuualue
- Jorma Lahtela

Tampere University Hospital

Julkaisutietokanta 29.4.2016

Publications Data Base 29.4.2016